Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Dutasteride/Tamsulosin Combination in BPH
NCT01673490Phase 4Terminated
- Sponsor
- GSK
- Start
- Jun 2012
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alpha blocker + 5-alpha reductase inhibitor in benign prostatic hyperplasia (BPH), sponsored by GSK. Started Jun 2012; status: terminated.
02
Drugs
alpha blocker + 5-alpha reductase inhibitor
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT01673490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01673490.